GPCR Modulation in Breast Cancer

Breast cancer is the most prevalent cancer found in women living in developed countries. Endocrine therapy is the mainstay of treatment for hormone-responsive breast tumors (about 70% of all breast cancers) and implies the use of selective estrogen receptor modulators and aromatase inhibitors. In co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lappano, Rosamaria, Jacquot, Yves, Maggiolini, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321247/
https://www.ncbi.nlm.nih.gov/pubmed/30513833
http://dx.doi.org/10.3390/ijms19123840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321247/
https://www.ncbi.nlm.nih.gov/pubmed/30513833
http://dx.doi.org/10.3390/ijms19123840

Ejemplares similares